期刊文献+

Salvianolic Acid B Down-regulates Matrix Metalloproteinase-9 Activity and Expression in Tumor Necrosis Factor-α-induced Human Coronary Artery Endothelial Cells 被引量:11

Salvianolic Acid B Down-regulates Matrix Metalloproteinase-9 Activity and Expression in Tumor Necrosis Factor-α-induced Human Coronary Artery Endothelial Cells
原文传递
导出
摘要 Background:Salvianolic acid B (Sal B) is a bioactive water-soluble compound of Salviae miltiorrhizae,a traditional herbal medicine that has been used clinically tor the treatment of cardiovascular diseases.This study sought to evaluate the effect of Sal B on matrix metalloproteinase-9 (MMP-9) and on the underlying mechanisms in tumor necrosis factor-α (TNF-α)-activated human coronary artery endothelial cells (HCAECs),a cell model of Kawasaki disease.Methods:HCAECs were pretreated with 1 l0 μmol/L of Sal B,and then stimulated by TNF-α at different time points.The protein expression and activity of MMP-9 were determined by Western blot assay and gelatin zymogram assay,respectively.Nuclear factor-κB (NF-κB) activation was detected with immunofluorescence,electrophoretic mobility shift assay,and Western blot assay.Protein expression levels of mitogen-activated protein kinase (c-Jun N-terminal kinase [JNK],extra-cellular signal-regulated kinase [ERK],and p38) were determined by Western blot assay.Results:After HCAECs were exposed to TNF-α,1-10 μtmol/L Sal B significantly inhibited TNF-α-induced MMP-9 expression and activity.Furthermore,Sal B significantly decreased IκBα phosphorylation and p65 nuclear translocation in HCAECs stimulated with TNF-α for 30 min.In addition,Sal B decreased the phosphorylation of JNK and ERK1/2 proteins in cells treated with TNF-α for 10 min.Conclusions:The data suggested that Sal B suppressed TNF-α-induced MMP-9 expression and activity by blocking the activation of NF-κB,JNK,and ERK1/2 signaling pathways. Background:Salvianolic acid B (Sal B) is a bioactive water-soluble compound of Salviae miltiorrhizae,a traditional herbal medicine that has been used clinically tor the treatment of cardiovascular diseases.This study sought to evaluate the effect of Sal B on matrix metalloproteinase-9 (MMP-9) and on the underlying mechanisms in tumor necrosis factor-α (TNF-α)-activated human coronary artery endothelial cells (HCAECs),a cell model of Kawasaki disease.Methods:HCAECs were pretreated with 1 l0 μmol/L of Sal B,and then stimulated by TNF-α at different time points.The protein expression and activity of MMP-9 were determined by Western blot assay and gelatin zymogram assay,respectively.Nuclear factor-κB (NF-κB) activation was detected with immunofluorescence,electrophoretic mobility shift assay,and Western blot assay.Protein expression levels of mitogen-activated protein kinase (c-Jun N-terminal kinase [JNK],extra-cellular signal-regulated kinase [ERK],and p38) were determined by Western blot assay.Results:After HCAECs were exposed to TNF-α,1-10 μtmol/L Sal B significantly inhibited TNF-α-induced MMP-9 expression and activity.Furthermore,Sal B significantly decreased IκBα phosphorylation and p65 nuclear translocation in HCAECs stimulated with TNF-α for 30 min.In addition,Sal B decreased the phosphorylation of JNK and ERK1/2 proteins in cells treated with TNF-α for 10 min.Conclusions:The data suggested that Sal B suppressed TNF-α-induced MMP-9 expression and activity by blocking the activation of NF-κB,JNK,and ERK1/2 signaling pathways.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第19期2658-2663,共6页 中华医学杂志(英文版)
基金 Acknowledgments We thank Medjaden and Editage for its linguistic assistance during the preparation of this manuscript. Financial support and sponsorship This study was supported by the grants from National Natural Science Foundation of China (No. 81274109, 30973238), Key Research Project of Beijing Natural Science Foundation (B)/Beijing Education Committee (No. KZ201010025024), and Project for Science and Technology Innovation, Beijing Education Committee (No. PXM2011 014226 07 000085).
关键词 Endothelial Cell Injury Kawasaki Disease Mitogen-activated Protein Kinase Matrix Metalloproteinase-9 Nuclear factor-κB Salvianolic Acid B Endothelial Cell Injury Kawasaki Disease Mitogen-activated Protein Kinase Matrix Metalloproteinase-9 Nuclear factor-κB Salvianolic Acid B
  • 相关文献

参考文献1

二级参考文献23

  • 1Du ZD, Zhao D, Du JB, et al. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004[J]. Pediatr Infect Dis J, 2007, 26:449-451. 被引量:1
  • 2Bums JC. The fiddle of Kawasaki disease [ J ] . N Engl J Med, 2007, 356:659-661. 被引量:1
  • 3JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease [ J ]. Cite J, 2010, 74:1989-2020. 被引量:1
  • 4Bayers S, Shulman ST, Paller AS. Kawasaki disease: part Ⅱ. Complications and treatment[ J]. J Am Acad Dermatol, 2013, 69:513. e1-8. 被引量:1
  • 5Takatsuki S, Ito Y, Takeuchi D, et al. IVIG reduced vascular oxidative stress in patients with Kawasaki disease [ J ] . Cric J, 2009, 73 : 1315-1318. 被引量:1
  • 6Ogata S, Shimizu C, Franco A, et al. Treatment response in kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G[ J]. Plos One, 2013, 8 :e81448. 被引量:1
  • 7Fumkawa S, Matsubara T, Iehiyama T. Regulation of proinflammatory cytokine cascade in Kawasaki disease [ J ]. Nihon Rinsho. 2008. 66:258-264. 被引量:1
  • 8Ichiyama T, Ueno Y, Isumi H, et al. An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial ceils of coronary arteries in vitro [ J ]. Inflamm Res, 2004, 53: 253-256. 被引量:1
  • 9Ichiyama T, Ueno Y, Hasegawa M, et al. Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages [ J ].Naunyn Schmiedebergs Arch Pharmacol, 2004, 369:428-433. 被引量:1
  • 10Murakami K, Suzuki C, Kobayashi F, et al. Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways [ J ] . Naunyn Schmiedebergs Arch Pharmacol, 2012, 385:891-898. 被引量:1

共引文献13

同被引文献96

引证文献11

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部